Concierge vs Traditional Care for Safe Peptide Therapy

Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery

Key Takeaways for Safe Peptide Therapy

• Concierge medicine uses smaller patient panels and longer visits, which supports the lab-driven oversight that peptide therapy requires. Traditional primary care’s high-volume model limits this level of attention.
• Practitioners like Ellie Pranckevicius, FNP-BC at Mirror Plastic Surgery, pair extensive clinical experience with personalized peptide protocols grounded in comprehensive lab review and direct patient access.
• Safe peptide therapy depends on baseline metabolic and hormonal testing, verified sourcing, individualized dosing, and ongoing monitoring. Short traditional visits rarely allow for all of these steps.
• Concierge models are expanding quickly and now offer extended consultations, real-time adjustments, and telemedicine access that responsible peptide care needs.
• Patients seeking lab-informed peptide therapy should schedule a consultation to receive a customized protocol tailored to their health profile.

Ellie’s Background in Peptide Therapy and Aesthetics

Ellie Pranckevicius, FNP-BC, leads peptide therapy and non-surgical aesthetics at Mirror Plastic Surgery. She holds a Bachelor’s in Health Science from Boston University, plus a Bachelor’s and Master’s in Nursing from the University of South Florida, and she completed a rigorous aesthetics licensure program. Her clinical foundation includes four years in the Neuroscience ICU at Tampa General Hospital, where she developed deep expertise in physiology, metabolic health, and complex patient recovery. Ellie also spent time at a high-end medical spa in Boston, which gave her a dual command of skin physiology and advanced clinical science that she now applies to every personalized peptide protocol.

Schedule a consultation with Ellie to begin a lab-driven assessment tailored to your health goals.

How Concierge and Traditional Models Differ for Peptide Care

Concierge medicine is a membership model in which patients pay a recurring fee for access to a physician or practitioner who maintains a significantly smaller panel. This structure supports longer visits and direct communication. Traditional primary care operates within insurance-billing structures, with panels of approximately 1,700–1,933 patients per family physician, having declined over the past decade from around 2,400, and visit durations that often average under 20 minutes. Direct primary care (DPC) is a related model that uses flat monthly fees and typically maintains panels of 400–800 patients, without the premium amenities of concierge programs.

Peptide supervision refers to the ongoing clinical oversight required to administer peptide protocols safely. This oversight includes baseline lab panels, iterative dosing adjustments, and monitoring for contraindications. Short traditional visits cannot accommodate a full review of thyroid, liver, kidney, hormone, and metabolic markers, along with the education needed for safe self-administration. That structural constraint makes traditional primary care a poor setting for responsible peptide therapy.

How Peptide Therapy Works at Mirror Plastic Surgery

The peptide consultation process at Mirror Plastic Surgery begins with a 30–60 minute appointment with Ellie. She reviews medical history, current medications, and health goals in detail. When clinically appropriate, especially for weight management or inflammatory conditions, she orders or reviews lab panels covering thyroid, liver, kidney, diabetes markers, and hormone levels before creating any protocol.

Ellie then designs custom peptide stacks around those results. Protocols may combine compounds such as BPC-157 for systemic inflammation, GHK-CU for collagen and skin health, NAD for mitochondrial energy, or GLP-3R for weight and metabolic support. Delivery is flexible. Patients in the Tampa Bay area can be seen in person at the St. Petersburg clinic, while patients across the United States, including Hawaii and Alaska, can access the full program remotely through telemedicine.

Ongoing support continues through direct text access to Ellie, which allows real-time dosing questions, refill requests, and protocol adjustments without long waits for follow-up visits. This loop of lab review, protocol refinement, and direct communication is structurally impossible in most traditional settings, where many adults have no after-hours access to their doctor’s office.

Growth of Concierge Care and Peptide Therapy

Concierge and direct primary care models are expanding rapidly. A study published in the December 2025 issue of Health Affairs, led by researchers from Johns Hopkins Carey Business School, Bloomberg School of Public Health, Oregon Health & Science University, and Harvard Medical School, found that these practices grew 83.1% between 2018 and 2023, from 1,658 to 3,036 practices, with clinicians in these models rising from 3,935 to 7,021.

Peptide therapy adoption is rising alongside this growth. Patients managing chronic inflammation, metabolic dysfunction, and age-related decline increasingly seek lab-driven, supervised protocols that short traditional visits cannot support. The concierge model’s structural features, including smaller panels, longer visits, and direct access, align closely with what responsible peptide oversight requires.

Personal Factors That Shape Peptide Safety

Several factors determine whether a peptide protocol will be safe and effective for an individual. The foundation is baseline labs. Metabolic, hormonal, and inflammatory markers must be established before dosing begins, because these results guide every later decision. Once the biomarker profile is clear, sourcing becomes critical. Peptides from providers with documented batch testing carry significantly lower contamination and dosing-error risk than unverified online products.

Even with clean sourcing and solid labs, personalization still matters. Genetics, diet, lifestyle, and existing conditions all influence outcomes, so a protocol that works for one patient may be inappropriate for another. Maintenance also plays a role. Benefits from peptide therapy usually require ongoing use, and stopping a protocol often allows the underlying condition to return to its prior state.¹ Outcome variability ties these elements together. At Mirror Plastic Surgery, illustrative outcomes have included reversal of autoimmune conditions such as psoriasis, measurable improvements in lipid panels, faster post-surgical recovery, and transitions from pharmaceutical SSRIs to nootropic peptides for anxiety management, although individual results are not guaranteed.¹

Risks, Limitations, and Access Challenges

The primary risk in peptide therapy usually comes from sourcing and supervision rather than the compounds themselves. Unregulated online peptide retailers often provide no third-party batch testing, no verification of active ingredient concentration, and no clinical screening for contraindications. Patients who self-administer without a baseline lab panel may unknowingly have pre-existing conditions such as thyroid dysfunction, liver impairment, or hormonal imbalances that make certain peptides unsafe.

Equity is a legitimate concern in the concierge model. Membership fees are an out-of-pocket expense not typically covered by insurance, which creates an access barrier for lower-income patients. This access problem becomes more acute when hospital-based concierge programs draw clinicians away from standard care and create a two-tier system within the same institution. The insurance gap compounds the issue. Labs and specialist visits may be covered, but the membership fee and peptide protocols themselves are not reimbursable under most standard plans, so patients carry the full cost even when they maintain traditional insurance.

Clearing Up Common Misconceptions

Peptides are only for weight loss.
GLP-1-class peptides receive significant media attention, but the peptide category is much broader. It includes systemic inflammation support (BPC-157, TB500), collagen and skin health (GHK-CU), mitochondrial energy (NAD), gut microbiome support (KPV), growth hormone stimulation (Sermorelin/Ipamorelin), anxiety management (Selank), and fertility support (Kisspeptin).

Concierge medicine is only for the wealthy.
Premium ultra-personalized programs can carry substantial fees, yet many contemporary programs begin at approximately $2,000–$5,000 per year. Some hospital-affiliated membership options are available at lower tiers, and HSA or FSA accounts can offset costs for eligible patients.

Results are identical across patients.
Peptide outcomes vary widely.¹ Genetics, metabolic baseline, lifestyle, and the specific stack used all shape the response. This variability is the reason a personalized, lab-informed protocol is safer and more appropriate than a standardized off-the-shelf approach.

Financial and System-Level Downsides of Concierge Care

Cost is the most frequently cited downside of concierge medicine. Membership fees are not covered by standard insurance plans, and patients continue to pay premiums and copays for covered services in addition to the membership. For patients with straightforward health needs and no chronic conditions, this added expense may not feel justified.

Access limitations also appear at the system level. The growth of concierge and DPC models raises questions about the broader healthcare system, particularly whether shifting clinicians into smaller-panel practices reduces availability for patients who cannot afford membership fees. The rapid expansion of concierge and direct primary care practices between 2018 and 2023 also introduces uncertainty about whether corporate ownership at scale will preserve the smaller panels and longer visits that define the model’s value.

When Concierge Medicine Justifies the Cost

For patients managing complex, multi-system conditions such as chronic inflammation, autoimmune disease, metabolic dysfunction, or age-related decline, the structural features of concierge medicine often address gaps that traditional care cannot fill. Most adults spend only a brief period with their primary care physician, and more than half report that their doctor knows them only somewhat or not at all.

The Centers for Medicare & Medicaid Services has acknowledged that longer, relationship-based primary care produces meaningfully better chronic disease management, a structure that concierge practices are built to deliver. For patients whose goals require iterative lab review, dosing adjustments, and direct practitioner access, the concierge model provides infrastructure that traditional care cannot realistically match. Whether the investment is worthwhile depends on the individual’s health complexity, goals, and how poorly short, infrequent visits have served them so far.

Why Many Doctors Move Into Concierge Practice

Physician burnout is a major driver of the shift toward concierge medicine. The American Medical Association reported that physician burnout reached 63% in 2021, and the Association of American Medical Colleges projected in March 2024 a U.S. physician shortage of up to 86,000 by 2036, with two in five physicians considering leaving practice within five years.

Insurance-mandated prior authorizations, peer-to-peer reviews, denials, and billing requirements contribute heavily to burnout and the physician shortage. Concierge models reduce administrative burden, restore clinical autonomy, and allow practitioners to manage complex conditions in-house with greater availability. MDVIP has reported high physician satisfaction and patient retention rates across its network.

Why Concierge Medicine Fits Peptide Therapy

Safe, customized peptide therapy has specific structural prerequisites. These include a comprehensive intake consultation, baseline biomarker testing, a personalized protocol built around those results, ongoing monitoring, and direct practitioner access for real-time adjustments. Every one of these requirements conflicts with the time constraints and large patient panels typical of traditional care.

Concierge practices that specialize in peptide oversight start every protocol with comprehensive lab review, design individualized stacks, and build iterative follow-up into the program from the beginning. At Mirror Plastic Surgery, Ellie Pranckevicius follows this framework. Lab panels inform the initial protocol, peptides meet the verified sourcing standards described earlier, and patients retain direct text access to Ellie throughout their program. The concierge model functions as a prerequisite for delivering peptide therapy responsibly.

Start your personalized peptide protocol by booking a consultation with Ellie today.

Frequently Asked Questions About Peptide Therapy

Are peptides FDA-regulated?
Most peptides used in wellness and optimization protocols are not FDA-regulated. They have been studied in clinical trials for over a decade and are used extensively worldwide. The main risk usually comes from obtaining them from unverified sources with no batch testing or quality controls. At Mirror Plastic Surgery, peptides are sourced exclusively from reputable providers with documented purity and potency testing, and every protocol follows a thorough medical history review and, when appropriate, lab panels.

Can peptide therapy be managed remotely?
Yes. Mirror Plastic Surgery’s full peptide program, including consultation, lab review, protocol creation, and ongoing support, is available remotely across the United States, including Hawaii and Alaska, through telemedicine. Patients receive detailed reconstitution and self-administration instructions, often with video demonstrations, and retain direct text access to Ellie for questions, adjustments, and refill requests throughout their protocol.

What happens if I stop taking peptides?
Benefits from peptide therapy typically diminish when a protocol is discontinued, similar to stopping any health regimen.¹ If inflammation was being managed by a peptide, it will likely return to its prior state once the protocol ends.¹ Most patients need a maintenance protocol to sustain the outcomes achieved during the initial program. Ellie discusses long-term maintenance planning during the consultation so patients understand the commitment before they begin.

Will my results be the same as someone else’s?
No. Peptide outcomes are highly individual and depend on genetics, metabolic baseline, diet, lifestyle, existing conditions, and the specific protocol used.¹ This variability is the reason Mirror Plastic Surgery conducts in-depth lab analysis and builds custom stacks rather than applying a standardized protocol. What resolves inflammation effectively in one patient may be inappropriate or insufficient for another.

Does concierge peptide care require in-person visits?
Not always. In-person consultations are available at Mirror Plastic Surgery’s St. Petersburg, Florida clinic, but the entire program can also be conducted remotely. Initial consultations, lab ordering, protocol delivery, and ongoing follow-up are all accessible through telemedicine. Patients who prefer in-person care in the Tampa Bay area can also be seen directly. Book an appointment with Ellie to determine the format that works best for your situation.

Choosing the Right Setting for Peptide Therapy

The structural differences between concierge medicine and traditional primary care directly affect peptide safety. Smaller patient panels, extended visit times, direct practitioner access, and iterative lab review create the conditions that make safe, personalized peptide therapy possible. Traditional primary care’s high-volume, short-visit model cannot support the baseline testing, dosing customization, and ongoing supervision that responsible peptide protocols require.

For health-conscious adults who have not achieved satisfactory results through conventional care, recognizing these structural prerequisites helps clarify whether concierge-level peptide oversight fits their goals. A thoughtful review of health complexity, desired outcomes, and past experiences with traditional care can guide the decision.

---